動物医療の世界市場予測（～2028年）：動物の種類別（コンパニオンアニマル、家畜動物）、疾患別（関節炎、アレルギー、皮膚疾患、消化器疾患）、地域別の分析

世界の動物医療の市場規模は、2021年の339億6,000万米ドルから、2028年には657億6,000万米ドルに達し、予測期間中のCAGRで9.9％の成長が予測されています。

当レポートでは、世界の動物医療市場について調査分析し、市場概要、市場動向、動物の種類別、疾患別、製品別、エンドユーザー別、地域別の市場分析や、企業プロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 序文

第3章 市場動向分析

• イントロダクション
• 促進要因
• 抑制要因
• 市場機会
• 脅威
• 製品分析
• エンドユーザー分析
• 新興市場
• COVID-19の影響

第4章 ポーターのファイブフォース分析

第5章 世界の動物医療市場：タイプ別

• イントロダクション
• 動物医療サービス
• 動物用医薬品
• 動物用医療機器

第6章 世界の動物医療市場：動物の種類別

• イントロダクション
• コンパニオンアニマル
  • 犬
  • 猫
  • 馬
  • 反すう動物
• 家畜動物
  • 牛
  • 羊
  • 水生動物
  • 豚
  • 家禽

第7章 世界の動物医療市場：疾患別

• イントロダクション
• 関節炎
• アレルギー
• 皮膚疾患
• 消化器疾患

第8章 世界の動物医療市場：製品別

• イントロダクション
• 診断器具
  • 分子診断
  • 臨床化学
  • 免疫診断検査
  • 画像診断
• 治療/医薬品
  • 抗炎症薬
  • 抗感染症薬
  • 寄生虫駆除剤
  • ワクチン
  • 薬用飼料添加物
  • 栄養飼料添加物

第9章 世界の動物医療市場：エンドユーザー別

• イントロダクション
• 動物病院
• 動物クリニック
• 動物用臨床検査サービス
• 薬局

第10章 世界の動物医療市場：地域別

• イントロダクション
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他
• 中東・アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他

第11章 主な発展

• 契約、提携、協業、合弁事業
• 買収と合併
• 新製品の発売
• 拡張
• その他の重要戦略

第12章 企業プロファイル

• Novartis International AG
• Eli Lilly and Company
• Bayer Healthcare
• Koninklijke DSM N.V
• Sanofi-Aventis
• MSD Animal Health
• Cargill Inc
• SeQuent Scientific Ltd
• Boehringer Ingelheim International GmbH
• Nutreco N.V.
• Phibro Animal Health
• Elanco Animal Health
• Ceva Animal Health Inc
• Merck Ltd
• Zoetis Animal Healthcare

List of Tables

• Table 1 Global Veterinary Healthcare Market Outlook, By Region (2020-2028) ($MN)
• Table 2 Global Veterinary Healthcare Market Outlook, By Type (2020-2028) ($MN)
• Table 3 Global Veterinary Healthcare Market Outlook, By Veterinary Services (2020-2028) ($MN)
• Table 4 Global Veterinary Healthcare Market Outlook, By Animal Medicine (2020-2028) ($MN)
• Table 5 Global Veterinary Healthcare Market Outlook, By Veterinary Medical Equipment (2020-2028) ($MN)
• Table 6 Global Veterinary Healthcare Market Outlook, By Animal Type (2020-2028) ($MN)
• Table 7 Global Veterinary Healthcare Market Outlook, By Companion Animals (2020-2028) ($MN)
• Table 8 Global Veterinary Healthcare Market Outlook, By Dogs (2020-2028) ($MN)
• Table 9 Global Veterinary Healthcare Market Outlook, By Cats (2020-2028) ($MN)
• Table 10 Global Veterinary Healthcare Market Outlook, By Horses (2020-2028) ($MN)
• Table 11 Global Veterinary Healthcare Market Outlook, By Ruminants (2020-2028) ($MN)
• Table 12 Global Veterinary Healthcare Market Outlook, By Livestock Animals (2020-2028) ($MN)
• Table 13 Global Veterinary Healthcare Market Outlook, By Cattle (2020-2028) ($MN)
• Table 14 Global Veterinary Healthcare Market Outlook, By Sheep (2020-2028) ($MN)
• Table 15 Global Veterinary Healthcare Market Outlook, By Aquatic (2020-2028) ($MN)
• Table 16 Global Veterinary Healthcare Market Outlook, By Swine (2020-2028) ($MN)
• Table 17 Global Veterinary Healthcare Market Outlook, By Poultry (2020-2028) ($MN)
• Table 18 Global Veterinary Healthcare Market Outlook, By Disease (2020-2028) ($MN)
• Table 19 Global Veterinary Healthcare Market Outlook, By Arthritis (2020-2028) ($MN)
• Table 20 Global Veterinary Healthcare Market Outlook, By Allergies (2020-2028) ($MN)
• Table 21 Global Veterinary Healthcare Market Outlook, By Dermatology Cases (2020-2028) ($MN)
• Table 22 Global Veterinary Healthcare Market Outlook, By Gastrointestinal Diseases (2020-2028) ($MN)
• Table 23 Global Veterinary Healthcare Market Outlook, By Product (2020-2028) ($MN)
• Table 24 Global Veterinary Healthcare Market Outlook, By Diagnostic Tools (2020-2028) ($MN)
• Table 25 Global Veterinary Healthcare Market Outlook, By Molecular Diagnostics (2020-2028) ($MN)
• Table 26 Global Veterinary Healthcare Market Outlook, By Clinical Chemistry (2020-2028) ($MN)
• Table 27 Global Veterinary Healthcare Market Outlook, By Immunodiagnostic Tests (2020-2028) ($MN)
• Table 28 Global Veterinary Healthcare Market Outlook, By Diagnostic Imaging (2020-2028) ($MN)
• Table 29 Global Veterinary Healthcare Market Outlook, By Therapeutics/Drugs (2020-2028) ($MN)
• Table 30 Global Veterinary Healthcare Market Outlook, By Anti-Inflammatories (2020-2028) ($MN)
• Table 31 Global Veterinary Healthcare Market Outlook, By Anti Infectives (2020-2028) ($MN)
• Table 32 Global Veterinary Healthcare Market Outlook, By Parasiticides (2020-2028) ($MN)
• Table 33 Global Veterinary Healthcare Market Outlook, By Vaccines (2020-2028) ($MN)
• Table 34 Global Veterinary Healthcare Market Outlook, By Medicinal Feed Additives (2020-2028) ($MN)
• Table 35 Global Veterinary Healthcare Market Outlook, By Nutritional Feed Additives (2020-2028) ($MN)
• Table 36 Global Veterinary Healthcare Market Outlook, By End User (2020-2028) ($MN)
• Table 37 Global Veterinary Healthcare Market Outlook, By Veterinary Hospitals (2020-2028) ($MN)
• Table 38 Global Veterinary Healthcare Market Outlook, By Veterinary Clinics (2020-2028) ($MN)
• Table 39 Global Veterinary Healthcare Market Outlook, By Veterinary Laboratory Testing Services (2020-2028) ($MN)
• Table 40 Global Veterinary Healthcare Market Outlook, By Pharmacies (2020-2028) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

According to Stratistics MRC, the Global Veterinary Healthcare Market is accounted for $37.32 billion in 2022 and is expected to reach $65.76 billion by 2028 growing at a CAGR of 9.9% during the forecast period. Veterinary healthcare can be defined as the science associated with the diagnosis, treatment, and prevention of diseases in animals. The scope of veterinary healthcare is broad covering various animal species both domestic and wild.

In 2021, the largest share of the health expenditure on prevention was spent on the surveillance, prevention, and control of infectious and parasitic diseases, which is expected given that the COVID-19 pandemic is not over yet. Over the course of 2021, the consumer healthcare market volume of products sold in Italian pharmacies was equal to roughly one billion units. According to data provided by New Line Ricerche di Mercato, self-medication products accounted for 46.4 percent of the total market volume, whereas diet food represented 6.4 percent of it.

Market Dynamics:

Driver:

Introduction of new policies

Introduction of new policies to pet owners is significantly influencing the demand of veterinary healthcare market. In the developed market, the penetration rate of pet insurance policies is very high. For instance, in the United States, the need for pet insurance policies is growing at a high CAGR during the forecast period. Similarly, in the UK, the penetration rate of pet insurance is 20%. The introduction of various pet insurance policies is solely increasing visits to veterinary healthcare centers or clinics.

Restraint:

Shortage of veterinarians

There is a decreasing number of veterinarians due to fewer training programs. Reluctance to adopt new technologies in undeveloped countries is a significant attribute for veterinarians' shortage in these places. Stringent rules and regulations are a significant challenge. Government authorities are imposing strict rules and regulations to approve a vaccine. It remains a major challenging factor for the key players. Some vaccines are unavailable against livestock vector-borne pathogens is hampering the growth rate of the market.

Opportunity:

Increasing investments in veterinary hospitals

Increasing investments in veterinary hospitals to ensure quality services is a significant factor anticipated to present growth opportunities for the market. The rise in the concern towards animal healthcare is lavishing the demand of the veterinary healthcare market. Also, growing

incidence of various health disorders among animals are ascribed to bolster the market's need. Pet lovers seek for best treatment procedure at any cost, which is also impacting the growth of the market towards positive. Increasing the livestock population is another attribute focused on expanding the demand of the market. Furthermore, people's need for quality poultry products for a healthy lifestyle is likely to extensively outshine the market's need.

Threat:

Fluctuations in the availability of raw materials

Fluctuations in the availability of raw materials and the unavailability of vaccines for some diseases restrict the market's demand. Additionally, increasing regulation on antibiotics is expected to remain a major challenge for the market. Apart from that, growing costs regulation related to animal testing is also a significant hurdle for the growth of the veterinary healthcare market.

COVID-19 Impact

Shortages of veterinary medicines and supply disruptions were observed in several countries, primarily due to the temporary lockdowns of manufacturing sites, export bans, and increased demand for medicine for the treatment of COVID-19. Governments are taking measures to mitigate the supply of medicines. For instance, in 2020, the European Medicines Agency issued guidance for companies responsible for veterinary medicines with respect to adaptations to the regulatory framework, primarily to address the challenges faced during this pandemic. Also, the Centers for Disease Control and Prevention, in July 2020, recommended certain guidelines to veterinary professionals for the treatment of companion animals during the COVID-19 pandemic.

The livestock animals segment is expected to be the largest during the forecast period

Livestock animals such as cattle and poultry are expected to experience higher medicalization rates during the forecast years. In emerging economies such as the Philippines and Vietnam, earlier, poultry health was neglected, and owners used to discard the chickens in bulk during a virus outbreak. Similar was the condition of a few cattle farms. Unorganized farms were often neglected, and that hampered the overall meat production in such countries. However, the current laws have been framed to scrutinize the situation in farms and ensure maximum animal protection.

The therapeutics/drugs segment is expected to have the highest CAGR during the forecast period

Therapeutics/drugs segment comprises of vaccines too.Vaccines are comprised of viruses, bacteria, or other disease-causing organisms that have been killed or altered so that they cannot cause any disease, thus, boosting immunity. Vaccines are being manufactured that contain genetically engineered components derived from those disease agents.

Region with largest share:

North America is projected to hold the largest market share owing to the increasing chronic diseases among animals. The US is the leading country with the highest shares of the market. The introduction of pet insurance policies and creating awareness over the availability of the different treatment processes for pet animals are anticipated to fuel the market's growth rate. Increasing expenditure on veterinary healthcare in the US is solely accelerating the market demand. Some people also treat animals as family members in these countries, hugely impacting the market's growth rate.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR due to the rise in the support from the government organizations through funds and focus on developing new drugs or vaccines in favor of the end-user.

Key players in the market

Some of the key players profiled in the Veterinary Healthcare Market include Novartis, International AG, Eli Lilly and Company, Bayer Healthcare, Koninklijke DSM N.V, Sanofi-Aventis, MSD Animal Health, Cargill Inc, SeQuent Scientific Ltd, Boehringer Ingelheim , International GmbH, Nutreco N.V., Phibro Animal Health, Elanco Animal Health, Ceva Animal Health Inc, Merck Ltd, and Zoetis Animal Healthcare.

Key developments:

In June 2020: Merck completed the acquisition of a Quantified Ag leading data analytics company that monitors cattle temperature and helps in the early detection of any disease. This acquisition will diversify Merck's veterinary product offerings and will positively impact the company's profitability.

In February 2020: Zoetis acquired Ethos Diagnostic Science. This acquisition will not only expand company's product portfolio but will also help the company to grow exponentially in the veterinary space.

In January 2020: Boehringer Ingelheim's launched a vaccine, VAXXITEK HVT+IBD+ND, that provides a strong immune foundation and optimized protection against Marek's Disease, Infectious Bursal Disease (classic and variant types), and Newcastle Disease.

Types Covered:

• Veterinary Services
• Animal Medicine
• Veterinary Medical Equipment

Animal Types Covered:

• Companion Animals
• Livestock Animals

Treatments Covered:

• Arthritis
• Allergies
• Dermatology Cases
• Gastrointestinal Diseases

Products Covered:

• Diagnostic Tools
• Therapeutics/Drugs

End Users Covered:

• Veterinary Hospitals
• Veterinary Clinics
• Veterinary Laboratory Testing Services
• Pharmacies

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Veterinary Healthcare Market, By Type

• 5.1 Introduction
• 5.2 Veterinary Services
• 5.3 Animal Medicine
• 5.4 Veterinary Medical Equipment

6 Global Veterinary Healthcare Market, By Animal Type

• 6.1 Introduction
• 6.2 Companion Animals
  • 6.2.1 Dogs
  • 6.2.2 Cats
  • 6.2.3 Horses
  • 6.2.4 Ruminants
• 6.3 Livestock Animals
  • 6.3.1 Cattle
  • 6.3.2 Sheep
  • 6.3.3 Aquatic
  • 6.3.4 Swine
  • 6.3.5 Poultry

7 Global Veterinary Healthcare Market, By Disease

• 7.1 Introduction
• 7.2 Arthritis
• 7.3 Allergies
• 7.4 Dermatology Cases
• 7.5 Gastrointestinal Diseases

8 Global Veterinary Healthcare Market, By Product

• 8.1 Introduction
• 8.2 Diagnostic Tools
  • 8.2.1 Molecular Diagnostics
  • 8.2.2 Clinical Chemistry
  • 8.2.3 Immunodiagnostic Tests
  • 8.2.4 Diagnostic Imaging
• 8.3 Therapeutics/Drugs
  • 8.3.1 Anti-Inflammatories
  • 8.3.2 Anti Infectives
  • 8.3.3 Parasiticides
  • 8.3.4 Vaccines
    • 8.3.4.1 Killed Inactivated Vaccines
    • 8.3.4.2 Modified Live Vaccines
  • 8.3.5 Medicinal Feed Additives
    • 8.3.5.1 Antioxidants
    • 8.3.5.2 Antibiotics
    • 8.3.5.3 Enzymes
    • 8.3.5.4 Vitamins
    • 8.3.5.5 Amino Acids
    • 8.3.5.6 Minerals
    • 8.3.5.7 Prebiotics
    • 8.3.5.8 Probiotics
  • 8.3.6 Nutritional Feed Additives

9 Global Veterinary Healthcare Market, By End User

• 9.1 Introduction
• 9.2 Veterinary Hospitals
• 9.3 Veterinary Clinics
• 9.4 Veterinary Laboratory Testing Services
• 9.5 Pharmacies

10 Global Veterinary Healthcare Market, By Geography

• 10.1 Introduction
• 10.2 North America
  • 10.2.1 US
  • 10.2.2 Canada
  • 10.2.3 Mexico
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 Italy
  • 10.3.4 France
  • 10.3.5 Spain
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 Japan
  • 10.4.2 China
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 New Zealand
  • 10.4.6 South Korea
  • 10.4.7 Rest of Asia Pacific
• 10.5 South America
  • 10.5.1 Argentina
  • 10.5.2 Brazil
  • 10.5.3 Chile
  • 10.5.4 Rest of South America
• 10.6 Middle East & Africa
  • 10.6.1 Saudi Arabia
  • 10.6.2 UAE
  • 10.6.3 Qatar
  • 10.6.4 South Africa
  • 10.6.5 Rest of Middle East & Africa

11 Key Developments

• 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 11.2 Acquisitions & Mergers
• 11.3 New Product Launch
• 11.4 Expansions
• 11.5 Other Key Strategies

12 Company Profiling

• 12.1 Novartis International AG
• 12.2 Eli Lilly and Company
• 12.3 Bayer Healthcare
• 12.4 Koninklijke DSM N.V
• 12.5 Sanofi-Aventis
• 12.6 MSD Animal Health
• 12.7 Cargill Inc
• 12.8 SeQuent Scientific Ltd
• 12.9 Boehringer Ingelheim International GmbH
• 12.10 Nutreco N.V.
• 12.11 Phibro Animal Health
• 12.12 Elanco Animal Health
• 12.13 Ceva Animal Health Inc
• 12.14 Merck Ltd
• 12.15 Zoetis Animal Healthcare